Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia

AstraZeneca

Status: Completed

Conditions: Chronic Heart Failure

Study type: Observational

Funder types: Industry

Identifiers

NCT00984529

NIS-CHR-ATA-2008/1

Details and patient eligibility

About

The purpose of this study is to determine whether treatment with candesartan cilexetil for at least 6 months in patients with chronic heart failure improves clinical signs and symptoms of chronic heart failure.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with diagnosed chronic heart failure
• Patients treated for at least 6 months with candesartan cilexetil
• Signed Informed consent

Exclusion criteria

• Hypersensitivity to candesartan cilexetil
• Pregnancy / lactation
• Severe hepatic impairment

Trial design

500 participants in 1 patient group

1

Description:

Cardiologist´s office patients